Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.

Also called NCT06900725

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06900725
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06900725. Randomized; no masking; primary purpose prevention. Start 2025-04-01 (anticipated); primary completion 2030-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke
Acronym
LEAVE-Stroke
Condition
Elderly
Condition
Atrial Fibrillation (AF)
Intervention (Drug)
edoxaban
Intervention (Drug)
Edoxaban 30 mg
Lead sponsor
National Taiwan University Hospital (class: other)
Collaborator
National Taiwan University Hospital, Yun-Lin Branch (class: other)
Collaborator
National Taiwan University Hospital Hsin-Chu Branch (class: other)

Record details

Record id
cardio:ct-nct06900725
Content hash
945d0f98c2744f1725d9cb87a3f336c4fba8a5517cc7192d3bd4a1d1f8772dc0